Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Journal of Toxicology and Environmental Health - Part A: Current Issues | journal | 0.494 Q2 | 99 | 151 | 239 | 5060 | 357 | 235 | 1.49 | 33.51 |  |
| 52 | British Journal of Clinical Pharmacology, Supplement | journal | 0.489 Q1 | 33 | 1 | 11 | 23 | 31 | 11 | 2.82 | 23.00 | |
| 53 | Alcohol and Alcoholism | journal | 0.475 Q2 | 109 | 105 | 269 | 3485 | 360 | 245 | 1.26 | 33.19 | |
| 54 | Journal of Chemotherapy | journal | 0.456 Q2 | 56 | 111 | 292 | 2182 | 328 | 285 | 1.13 | 19.66 | |
| 55 | Journal of Liposome Research | journal | 0.450 Q1 | 64 | 33 | 117 | 1006 | 118 | 101 | 1.03 | 30.48 | |
| 56 | Expert Opinion on Therapeutic Patents | journal | 0.439 Q2 | 88 | 150 | 402 | 6755 | 392 | 397 | 1.04 | 45.03 | |
| 57 | International Journal of Neuropsychopharmacology | journal | 0.432 Q2 | 125 | 47 | 66 | 1989 | 65 | 66 | 0.98 | 42.32 | |
| 58 | Fundamental and Clinical Pharmacology | journal | 0.410 Q2 | 85 | 62 | 276 | 2075 | 282 | 273 | 1.25 | 33.47 | |
| 59 | Antiviral Therapy | journal | 0.409 Q2 | 93 | 39 | 201 | 566 | 151 | 184 | 0.92 | 14.51 | |
| 60 | Tumor Targeting | journal | 0.404 Q2 | 10 | 0 | 54 | 0 | 56 | 52 | 1.04 | 0.00 | |
| 61 | International Journal of Pharmacy Practice | journal | 0.387 Q2 | 44 | 40 | 101 | 1160 | 99 | 96 | 0.97 | 29.00 | |
| 62 | Expert Opinion on Investigational Drugs | journal | 0.365 Q2 | 117 | 278 | 449 | 19174 | 510 | 446 | 1.17 | 68.97 | |
| 63 | International Journal of Cosmetic Science | journal | 0.355 Q2 | 77 | 46 | 96 | 1006 | 65 | 96 | 0.59 | 21.87 | |
| 64 | ChemMedChem | journal | 0.352 Q2 | 119 | 118 | 355 | 2163 | 235 | 354 | 0.68 | 18.33 | |
| 65 | Inhalation Toxicology | journal | 0.344 Q3 | 97 | 171 | 174 | 5654 | 183 | 169 | 0.92 | 33.06 | |
| 66 | Biopharmaceutics and Drug Disposition | journal | 0.336 Q2 | 65 | 42 | 210 | 1010 | 180 | 207 | 0.89 | 24.05 | |
| 67 | Phytotherapy Research | journal | 0.336 Q2 | 158 | 137 | 530 | 3221 | 279 | 527 | 0.52 | 23.51 | |
| 68 | Toxin Reviews | journal | 0.336 Q3 | 54 | 12 | 92 | 873 | 73 | 89 | 0.77 | 72.75 | |
| 69 | ATLA Alternatives to Laboratory Animals | journal | 0.331 Q3 | 65 | 72 | 164 | 1473 | 136 | 143 | 0.85 | 20.46 | |
| 70 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.327 Q4 | 54 | 137 | 675 | 1959 | 321 | 672 | 0.46 | 14.30 | |
| 71 | Journal of Food Biochemistry | journal | 0.323 Q2 | 64 | 34 | 93 | 867 | 59 | 93 | 0.53 | 25.50 | |
| 72 | Autonomic and Autacoid Pharmacology | journal | 0.317 Q3 | 24 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 73 | Drug Stability | journal | 0.317 Q2 | 7 | 0 | 10 | 0 | 7 | 10 | 0.00 | 0.00 | |
| 74 | Toxicology Methods | journal | 0.316 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 75 | Toxicology in Vitro | journal | 0.313 Q3 | 125 | 62 | 285 | 2087 | 241 | 282 | 0.78 | 33.66 | |
| 76 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.311 Q3 | 25 | 25 | 44 | 685 | 40 | 29 | 0.59 | 27.40 | |
| 77 | Immunopharmacology and Immunotoxicology | journal | 0.311 Q3 | 61 | 45 | 128 | 1523 | 129 | 128 | 0.95 | 33.84 | |
| 78 | Journal of Pharmacy and Pharmacology | journal | 0.310 Q2 | 137 | 569 | 1617 | 8068 | 1109 | 1580 | 0.60 | 14.18 | |
| 79 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.303 Q3 | 81 | 59 | 186 | 2060 | 150 | 169 | 0.93 | 34.92 | |
| 80 | Journal of Applied Toxicology | journal | 0.297 Q3 | 103 | 97 | 204 | 2685 | 191 | 203 | 0.86 | 27.68 | |
| 81 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.291 Q3 | 57 | 36 | 113 | 840 | 60 | 105 | 0.51 | 23.33 | |
| 82 | Chemical Speciation and Bioavailability | journal | 0.284 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 83 | Current Opinion in Molecular Therapeutics | journal | 0.283 Q3 | 67 | 90 | 93 | 4584 | 63 | 87 | 0.68 | 50.93 | |
| 84 | Advances in Antiviral Drug Design | book series | 0.268 Q2 | 12 | 0 | 7 | 0 | 1 | 5 | 0.14 | 0.00 | |
| 85 | Drug Delivery | journal | 0.264 Q2 | 95 | 32 | 105 | 853 | 70 | 105 | 0.48 | 26.66 | |
| 86 | Pharmacy and Pharmacology Communications | journal | 0.260 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 87 | International Antiviral News | journal | 0.249 Q3 | 8 | 23 | 103 | 756 | 40 | 69 | 0.44 | 32.87 | |
| 88 | Expert Opinion on Emerging Drugs | journal | 0.243 Q3 | 54 | 25 | 63 | 2057 | 49 | 61 | 0.80 | 82.28 | |
| 89 | Acta Pharmacologica Sinica | journal | 0.238 Q3 | 117 | 218 | 517 | 3925 | 292 | 517 | 0.56 | 18.00 | |
| 90 | Pharmacology Communications | journal | 0.234 Q3 | 8 | 0 | 28 | 0 | 11 | 28 | 0.00 | 0.00 | |
| 91 | Reviews in Contemporary Pharmacotherapy | journal | 0.229 Q3 | 18 | 17 | 93 | 2155 | 94 | 93 | 1.13 | 126.76 | |
| 92 | Pharmaceutical Journal | journal | 0.218 Q3 | 28 | 302 | 1174 | 2157 | 151 | 605 | 0.13 | 7.14 | |
| 93 | Pharmaceutical Medicine | journal | 0.210 Q3 | 25 | 68 | 179 | 473 | 34 | 132 | 0.18 | 6.96 | |
| 94 | Pharmaceutical Sciences | journal | 0.200 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 95 | Paediatric and Perinatal Drug Therapy | journal | 0.197 Q3 | 20 | 17 | 121 | 264 | 27 | 120 | 0.57 | 15.53 | |
| 96 | Pharmaceutical Biology | journal | 0.193 Q3 | 88 | 76 | 292 | 1581 | 67 | 288 | 0.13 | 20.80 | |
| 97 | BioDrugs | journal | 0.187 Q3 | 79 | 81 | 251 | 5271 | 174 | 240 | 0.79 | 65.07 | |
| 98 | Pharmacology and Toxicology, Supplement | journal | 0.170 Q3 | 7 | 10 | 41 | 246 | 9 | 41 | 0.19 | 24.60 | |
| 99 | Pharmacology Reviews and Communications | journal | 0.158 Q3 | 9 | 11 | 73 | 339 | 16 | 73 | 0.28 | 30.82 | |
| 100 | Toxic Substance Mechanisms | journal | 0.151 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data